A protein called FH may help hold back glioblastoma in lab and mouse tests
Original title: Fumarate hydratase suppresses glioblastoma progression by restricting fumarate-mediated succination of TRIM17.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice, not in people.
The short version
Scientists found a protein that seems to slow glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary growth in lab cells and in mice.
What was studied. Researchers looked at glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary tumor samples from patients and at glioblastoma cells grown in the lab. They also tested tumors grown in mice. They studied a protein called fumarate hydratase, or FH.
What they found. glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary samples from patients had much less FH than normal. When the researchers raised FH in glioblastoma cells, the cells were less able to survive, move, and spread. When they lowered or blocked FH, the cells did the opposite. Less FH let a substance called fumarate build up, and that change made another protein, TRIM17, break down faster. Tests in mice supported the same idea.
What this means, and what it doesn't
What it could mean: This points to a possible new target for future glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary drugs. It helps explain how these tumors may use changes in cell chemistry to grow. Nothing here is a treatment a patient can ask for.
What it doesn't mean: This does not mean there is a new treatment. The work was done in cells and in mice, not in people. No one has tested this in a human trial. It is not a promise of a cure, and it will not change your care today. Many findings like this never turn into a drug, and any that do take years.
Source: PubMed, August 7, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.